These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Absorption of bismuth from two bismuth compounds before and after healing of peptic ulcers. Hundal O; Bergseth M; Gharehnia B; Andersen KJ; Berstad A Hepatogastroenterology; 1999; 46(29):2882-6. PubMed ID: 10576366 [TBL] [Abstract][Full Text] [Related]
10. Maintenance therapy with colloidal bismuth subcitrate in duodenal ulcer disease. Bianchi Porro G; Lazzaroni M; Cortvriendt WR Digestion; 1987; 37 Suppl 2():47-52. PubMed ID: 3305118 [TBL] [Abstract][Full Text] [Related]
11. Controlled trial comparing colloidal bismuth subcitrate tablets, cimetidine and placebo in the treatment of gastric ulceration. Tytgat GN; van Bentem N; van Olffen G; Dekker W; Rutgeerts L; de Boer J Scand J Gastroenterol Suppl; 1982; 80():31-8. PubMed ID: 6761850 [No Abstract] [Full Text] [Related]
12. Uptake and subcellular localisation of bismuth in the gastrointestinal mucosa of rats after short term administration of colloidal bismuth subcitrate. Stiel D; Murray DJ; Peters TJ Gut; 1985 Apr; 26(4):364-8. PubMed ID: 3979909 [TBL] [Abstract][Full Text] [Related]
13. The effect of histamine H2-receptor blockade on bismuth absorption from three ulcer-healing compounds. Nwokolo CU; Prewett EJ; Sawyerr AM; Hudson M; Pounder RE Gastroenterology; 1991 Oct; 101(4):889-94. PubMed ID: 1889712 [TBL] [Abstract][Full Text] [Related]
14. Comparison of plasma bismuth levels after oral dosing with basic bismuth carbonate or tripotassium dicitrato bismuthate. Madaus S; Schulte-Frohlinde E; Scherer C; Kämmereit A; Schusdziarra V; Classen M Aliment Pharmacol Ther; 1992 Apr; 6(2):241-9. PubMed ID: 1288519 [TBL] [Abstract][Full Text] [Related]
15. Reversible nephrotoxicity after overdose of colloidal bismuth subcitrate. Işlek I; Uysal S; Gök F; Dündaröz R; Küçüködük S Pediatr Nephrol; 2001 Jun; 16(6):510-4. PubMed ID: 11420918 [TBL] [Abstract][Full Text] [Related]
16. Colloidal bismuth subcitrate evokes adaptive cytoprotection in rat gastric mucosa. Balint GA Acta Med Hung; 1991; 48(3-4):197-201. PubMed ID: 1822857 [TBL] [Abstract][Full Text] [Related]
17. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate. Miller JP; Hollanders D; Ravenscroft MM; Tweedle DE; Martin DF Scand J Gastroenterol Suppl; 1982; 80():39-42. PubMed ID: 6761851 [TBL] [Abstract][Full Text] [Related]
18. Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia. Vaira D; Holton J; Ainley C; Falzon M; Osborn J; D'Anna L; Romanos A; Chandrakumaran K; McNeil I Ital J Gastroenterol; 1992 Sep; 24(7):400-4. PubMed ID: 1392023 [TBL] [Abstract][Full Text] [Related]
19. Hepatic and cerebrospinal fluid accumulation of aluminium and bismuth in volunteers taking short course anti-ulcer therapy. Gane E; Sutton MM; Pybus J; Hamilton I J Gastroenterol Hepatol; 1996 Oct; 11(10):911-5. PubMed ID: 8912126 [TBL] [Abstract][Full Text] [Related]